4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-24-000016
CIK 0001133416other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:47 PM ET
Size
5.2 KB
Accession
0001133416-24-000016
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-24+50,000→ 50,000 totalExercise: $1.72Exp: 2034-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2024.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:47 PM ET
- Size
- 5.2 KB